Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis

The increased level of low-density lipoprotein cholesterol (LDL-CH) is one of the risk factors (RFs) of coronary heart disease and atherosclerosis. Statins, with their vast evidence base on mortality reduction, are the principal medications in atherosclerosis treatment. The results of the recent con...

Full description

Saved in:
Bibliographic Details
Main Authors: A. V. Susekov, N. B. Gornyakova, M. Yu. Zubareva, T. A. Rozhkova, E. Yu. Solovyeva
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2009-12-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1520
Tags: Add Tag
No Tags, Be the first to tag this record!